CLIA-waived rapid immunofluorescence assay (FIA) test kit for qualitative detection of fentanyl in oral fluid samples. Enables quick screening in clinical and point-of-care settings with 510(k) clearance for reliable drug presence identification.
Manufactured by
Houston, TX, United States
Healgen Scientific, a wholly owned subsidiary of Zhejiang Orient Gene Biotech Co.,Ltd, develops, manufactures and commercializes in-vitro diagnostic test systems worldwide. Our product portfolio spans multiple testing categories and analytes to meet various clinical and laboratory needs. Our testing platforms include rapid testing, molecular diagnostics, and multiplex flow cytometry. Since our inception in 2007, we have strived to develop devices that meet and exceed industry standards. The manufacturing process is supported by our interactive and highly-skilled Research and Development team, who are actively redefining the efficiency and design of our products. Our ambition is worldwide, and we currently provide products to customers in: USA, Europe, Middle-East, South Asia, Africa and Latin America for a total of 80+ countries. Our mission is to provide premier support to our distributors and partners. We have a flexible strategy on business cooperation, where we offer OEM options. Our success is supported by our professional personnel and good manufacturing practice. Healgen™ and DIAGNOSTAR™ are registered trademarks of Healgen Scientific LLC. These are produced and manufactured by Healgen Scientific LLC.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Xiamen Biotime Biotechnology Co., Ltd.
China · 10 relevant products
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 5 relevant products
InTec PRODUCTS, INC.
China · 1 relevant product
BioTeke Corporation(wuxi) Co.,Ltd
China · 1 relevant product
ChangChun WanCheng Bio-Electron Co., Ltd.
China · 1 relevant product
ACRO BIOTECH INC.
United States · 1 relevant product
Lansion Biotechnology Co., Ltd.
China · 1 relevant product
Nantong Egens Biotechnology Co., Ltd.
China · 1 relevant product
Delta Care For Medical Industries
Egypt · 1 relevant product
Innovation Biotech (Beijing) Co., Ltd
China · 1 relevant product
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 100 closest product alternatives
Xiamen Biotime Biotechnology Co., Ltd. · China
Fluorescence immunoassay test for tumor marker detection. Supports cancer screening, diagnosis, and monitoring in clinical practice.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Tumor marker rapid diagnostic tests utilizing Fluorescence Immunoassay technology for quantitative measurement. Compatible with automated fluorescence immunoassay readers, these tests provide high sensitivity and accurate, reproducible results for clinical analysis.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid screening diagnostic assays that detect key oncology markers including AFP, CEA, PSA, and FOB with low sample volume requirements. Designed to facilitate accessible early-stage risk stratification and are ideal for large-scale population health screening programs.
InTec PRODUCTS, INC. · China
Rapid immunochromatographic assay for qualitative detection of tumor marker antigens. Point-of-care diagnostic test for cancer screening and monitoring.
BioTeke Corporation(wuxi) Co.,Ltd · China
Immunoassay-based test for rapid detection of tumor-associated markers in clinical samples. Supports oncology screening and cancer diagnostics in clinical laboratories.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid screening assays for AFP, CEA, PSA, and other key oncology markers enabling accessible, early-stage risk stratification in community health screening and specialist oncology settings. Offers quantitative fluorescence and semi-quantitative formats with low sample volume requirements of 50–100 µL serum/plasma. Multi-marker combo panels are available.
ChangChun WanCheng Bio-Electron Co., Ltd. · China
Rapid diagnostic test kit for detection of tumor-associated antigens in blood or tissue samples. Aids in cancer screening and oncology monitoring.
ACRO BIOTECH INC. · United States
Rapid diagnostic tests for tumor marker detection, enabling quick identification of cancer-related biomarkers in clinical specimens. These tests support oncology screening and patient monitoring through accelerated processing times without compromising diagnostic accuracy.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for oncology marker detection. Enables rapid assessment of cancer-related biomarkers.
Xiamen Biotime Biotechnology Co., Ltd. · China
Fluorescence immunoassay test for infectious disease markers. Detects pathogens and disease-specific antibodies for infectious disease diagnosis.
Nantong Egens Biotechnology Co., Ltd. · China
In vitro diagnostic kits for detection and quantification of cancer biomarkers in patient samples. Available in multiple formats including ELISA and CLIA for oncology applications.
Delta Care For Medical Industries · Egypt
A rapid diagnostic test for the detection of tumor markers. Used for screening and monitoring cancer-related biomarkers in clinical settings.
88 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products